Skip to main content
. 2021 Feb 26;47(3):265–281. doi: 10.1007/s00134-020-06341-7
Recommendations pertaining to the process of determining a prognosis that justifies the withdrawal of life-sustaining treatment
Health authorities, professionals and professional associations should evaluate the circumstances of patients dying in ICUs. In countries where WLST is an accepted practice in the consideration of treatment futility and end-of-life care, the possibility of developing a cDCDD program as a routine component of end-of-life care should be explored
The cDCDD program must be developed with a comprehensive regulatory framework that emphasizes the independence of decisions related to the WLST from the consideration of organ donation
Transplant healthcare professionals must not be involved in reaching the decision to WLST nor in the actions involved in the WLST